Skip to content


Nikita (pitavastatin) is a small molecule pharmaceutical. Pitavastatin was first approved as Nikita on 2017-08-04. It is used to treat hypercholesterolemia, hyperlipoproteinemias, and hypertriglyceridemia in the USA. It is known to target 3-hydroxy-3-methylglutaryl-Coenzyme A reductase.
Trade Name Nikita
Common Name Pitavastatin
Indication hypercholesterolemia, hyperlipoproteinemias, hypertriglyceridemia
Drug Class Enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors)
Get full access now